Financhill
Buy
66

ARQT Quote, Financials, Valuation and Earnings

Last price:
$15.01
Seasonality move :
71.61%
Day range:
$14.18 - $15.79
52-week range:
$2.60 - $15.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.31x
P/B ratio:
11.20x
Volume:
5.2M
Avg. volume:
2.2M
1-year change:
478.76%
Market cap:
$1.8B
Revenue:
$59.6M
EPS (TTM):
-$1.79
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $3.7M $59.6M
Revenue Growth (YoY) -- -- -- -- 1517.09%
 
Cost of Revenues -- -- -- $754K $5M
Gross Profit -- -- -- $2.9M $54.6M
Gross Profit Margin -- -- -- 79.54% 91.63%
 
R&D Expenses $36.5M $115.3M $145.6M $182.4M $110.6M
Selling, General & Admin $6.6M $21.3M $61M $122.1M $185.1M
Other Inc / (Exp) $1.1M $967K $173K $5.8M $11.8M
Operating Expenses $43.1M $136.6M $206.5M $304.6M $295.7M
Operating Income -$43.1M -$136.6M -$206.5M -$301.6M -$241.1M
 
Net Interest Expenses -- -- -- $15.7M $29.7M
EBT. Incl. Unusual Items -$42M -$135.7M -$206.4M -$311.5M -$259M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $3.1M
Net Income to Company -$42M -$135.7M -$206.4M -$311.5M -$262.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$42M -$135.7M -$206.4M -$311.5M -$262.1M
 
Basic EPS (Cont. Ops) -$1.20 -$3.80 -$4.18 -$5.66 -$3.78
Diluted EPS (Cont. Ops) -$1.20 -$3.80 -$4.18 -$5.66 -$3.78
Weighted Average Basic Share $35.1M $35.7M $49.4M $55M $69.3M
Weighted Average Diluted Share $35.1M $35.7M $49.4M $55M $69.3M
 
EBITDA -$43.1M -$135.6M -$205.9M -$294.9M -$227.8M
EBIT -$43.1M -$135.7M -$206.4M -$295.8M -$229.3M
 
Revenue (Reported) -- -- -- $3.7M $59.6M
Operating Income (Reported) -$43.1M -$136.6M -$206.5M -$301.6M -$241.1M
Operating Income (Adjusted) -$43.1M -$135.7M -$206.4M -$295.8M -$229.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $725K $38.1M $44.8M
Revenue Growth (YoY) -- -- -- 5156.41% 17.44%
 
Cost of Revenues -- -- $269K $1.2M $5.5M
Gross Profit -- -- $456K $36.9M $39.3M
Gross Profit Margin -- -- 62.9% 96.9% 87.7%
 
R&D Expenses $32.7M $40.6M $69.7M $26.2M $19.5M
Selling, General & Admin $5.6M $16.5M $35.5M $47.6M $58.8M
Other Inc / (Exp) $99K $98K $1.9M $2.7M $4.2M
Operating Expenses $38.3M $57.1M $105.2M $73.8M $78.3M
Operating Income -$38.3M -$57.1M -$104.7M -$36.9M -$39.1M
 
Net Interest Expenses -- -- $4.9M $7.6M $6.7M
EBT. Incl. Unusual Items -$38.2M -$57M -$107.7M -$41.7M -$41.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $3M --
Net Income to Company -$38.2M -$57M -$107.7M -$44.8M -$41.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$38.2M -$57M -$107.7M -$44.8M -$41.5M
 
Basic EPS (Cont. Ops) -$1.01 -$1.14 -$1.89 -$0.73 -$0.33
Diluted EPS (Cont. Ops) -$1.01 -$1.14 -$1.89 -$0.73 -$0.33
Weighted Average Basic Share $37.7M $50.1M $57.1M $61.7M $124.3M
Weighted Average Diluted Share $37.7M $50.1M $57.1M $61.7M $124.3M
 
EBITDA -$38.3M -$56.9M -$102.5M -$33.8M -$33.5M
EBIT -$38.3M -$57M -$102.8M -$34.2M -$34.9M
 
Revenue (Reported) -- -- $725K $38.1M $44.8M
Operating Income (Reported) -$38.3M -$57.1M -$104.7M -$36.9M -$39.1M
Operating Income (Adjusted) -$38.3M -$57M -$102.8M -$34.2M -$34.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $49M $138.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $3.2M $14.5M
Gross Profit -- -- $456K $45.8M $124.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $98.7M $120.4M $201.1M $120.7M $85.7M
Selling, General & Admin $16.9M $48.9M $103.8M $173.5M $220.5M
Other Inc / (Exp) $1.4M $228K $2.5M $12.4M $16.1M
Operating Expenses $115.6M $169.3M $304.9M $294.2M $306.2M
Operating Income -$115.6M -$169.3M -$304.5M -$248.4M -$181.9M
 
Net Interest Expenses -- -- $4.9M $28.9M $29.4M
EBT. Incl. Unusual Items -$114.2M -$169.1M -$310.8M -$264.9M -$195.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $3M $349K
Net Income to Company -$114.2M -$169.1M -$310.8M -$267.9M -$195.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$114.2M -$169.1M -$310.8M -$267.9M -$195.5M
 
Basic EPS (Cont. Ops) -$3.46 -$3.48 -$5.89 -$4.38 -$1.79
Diluted EPS (Cont. Ops) -$3.46 -$3.53 -$5.89 -$4.38 -$1.79
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$115.5M -$167.8M -$301.3M -$234.5M -$163.3M
EBIT -$115.6M -$168.1M -$302M -$236M -$165.8M
 
Revenue (Reported) -- -- -- $49M $138.7M
Operating Income (Reported) -$115.6M -$169.3M -$304.5M -$248.4M -$181.9M
Operating Income (Adjusted) -$115.6M -$168.1M -$302M -$236M -$165.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- $725K $46.1M $125.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $269K $2.7M $12.2M
Gross Profit -- -- $456K $43.3M $113M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $87.9M $93M $148.6M $86.8M $61.9M
Selling, General & Admin $14.6M $42.2M $85.1M $136.5M $171.8M
Other Inc / (Exp) $952K $213K $2.5M $9M $13.5M
Operating Expenses $102.6M $135.2M $233.7M $223.3M $233.7M
Operating Income -$102.6M -$135.2M -$233.2M -$179.9M -$120.8M
 
Net Interest Expenses -- -- $4.9M $22M $21.6M
EBT. Incl. Unusual Items -$101.6M -$135M -$239.4M -$192.8M -$128.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $3M $324K
Net Income to Company -$101.6M -$135M -$239.4M -$195.9M -$129.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$101.6M -$135M -$239.4M -$195.9M -$129.3M
 
Basic EPS (Cont. Ops) -$3.10 -$2.74 -$4.47 -$3.20 -$1.07
Diluted EPS (Cont. Ops) -$3.10 -$2.74 -$4.47 -$3.20 -$1.07
Weighted Average Basic Share $99.6M $147.4M $159M $184.3M $358.8M
Weighted Average Diluted Share $99.6M $147.4M $159M $184.3M $358.8M
 
EBITDA -$102.5M -$134.7M -$230.1M -$169.7M -$105.2M
EBIT -$102.6M -$135M -$230.7M -$170.9M -$107.3M
 
Revenue (Reported) -- -- $725K $46.1M $125.2M
Operating Income (Reported) -$102.6M -$135.2M -$233.2M -$179.9M -$120.8M
Operating Income (Adjusted) -$102.6M -$135M -$230.7M -$170.9M -$107.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $63.3M $65.1M $96.4M $53.6M $88.4M
Short Term Investments $37.9M $219.4M $290.6M $355.9M $183.5M
Accounts Receivable, Net -- -- -- $8.5M $25.8M
Inventory -- -- -- $7.5M $13.1M
Prepaid Expenses $3.3M $6.3M $6.1M $4.4M $10.5M
Other Current Assets -- -- $8M $6.3M $8.2M
Total Current Assets $106.5M $292.8M $402.8M $437.4M $330.4M
 
Property Plant And Equipment $491K $5.4M $5.3M $4.6M $3.9M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $47K $78K $78K $78K $596K
Total Assets $107M $298.3M $408.2M $449.3M $341.4M
 
Accounts Payable $1.4M $7.1M $7.4M $8.8M $12M
Accrued Expenses $2.3M $11M $16.4M $14.3M $19.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $178K -- $433K $657K $735K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5.2M $22.6M $33.3M $37.8M $46.7M
 
Long-Term Debt -- -- $72.4M $197.8M $201.8M
Capital Leases -- -- -- -- --
Total Liabilities $172M $27.6M $110.5M $239.7M $252.7M
 
Common Stock -- $4K $5K $6K $9K
Other Common Equity Adj -$1K -$2K -$255K -$1.1M $4K
Common Equity -$65M $270.6M $297.7M $209.6M $88.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$65M $270.6M $297.7M $209.6M $88.7M
 
Total Liabilities and Equity $107M $298.3M $408.2M $449.3M $341.4M
Cash and Short Terms $101.3M $284.4M $387.1M $409.6M $271.9M
Total Debt -- -- -- $197.8M $201.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $45.7M $51.8M $81.5M $107.5M $134.9M
Short Term Investments $144M $315.5M $395.4M $119.6M $195.7M
Accounts Receivable, Net -- -- $2.4M $19.4M $60.1M
Inventory -- -- $4.3M $13.9M $14M
Prepaid Expenses $3.3M $12.6M $11.8M $10M $9.7M
Other Current Assets -- -- -- $10.2M $8.7M
Total Current Assets $194.1M $381.8M $496.7M $281.5M $423.7M
 
Property Plant And Equipment $3.8M $5.2M $4.7M $4.2M $3.2M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $78K $78K $78K $596K $596K
Total Assets $198M $387M $508.9M $293M $437.4M
 
Accounts Payable $5M $4.9M $8.7M $13.2M $19.3M
Accrued Expenses $13.2M $7.1M $16.3M $14.3M $37.2M
Current Portion Of Long-Term Debt -- -- -- -- $99.5M
Current Portion Of Capital Lease Obligations $32K $306K $639K $715K $798K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $21.2M $19.1M $37.1M $41.9M $172.4M
 
Long-Term Debt -- -- $196.8M $200.8M $105.1M
Capital Leases -- -- -- -- --
Total Liabilities $24.9M $24M $238.1M $246.2M $280.7M
 
Common Stock $4K $5K $6K $6K $12K
Other Common Equity Adj $4K -$18K -$1.6M -$184K $533K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $173.1M $363M $270.8M $46.7M $156.6M
 
Total Liabilities and Equity $198M $387M $508.9M $293M $437.4M
Cash and Short Terms $189.7M $367.3M $477M $227.1M $330.6M
Total Debt -- -- $196.8M $200.8M $204.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$42M -$135.7M -$206.4M -$311.5M -$262.1M
Depreciation & Amoritzation $68K $122K $454K $934K $1.5M
Stock-Based Compensation $824K $7.9M $23.9M $32.7M $38.8M
Change in Accounts Receivable -- -- -- -$8.5M -$17.3M
Change in Inventories -- -- -- -$7.5M -$5.6M
Cash From Operations -$42.8M -$113M -$174.6M -$257.7M -$247.1M
 
Capital Expenditures -- -- -- $23.3M $428K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$26.3M -$181.8M -$76M -$87.2M $180.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $74M $125M --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$1.4M -- -$1.6M -$2.2M --
Cash From Financing $93.1M $298.1M $281.9M $301.8M $101.3M
 
Beginning Cash (CF) $39.4M $63.3M $66.6M $98M $54.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $23.9M $3.3M $31.4M -$43.1M $34.5M
Ending Cash (CF) $63.3M $66.6M $98M $54.9M $89.3M
 
Levered Free Cash Flow -$43.1M -$113.4M -$175.6M -$281M -$247.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$38.2M -$57M -$107.7M -$44.8M -$41.5M
Depreciation & Amoritzation $30K $116K $282K $387K $1.4M
Stock-Based Compensation $2.3M $5.4M $8.8M $10M $9.8M
Change in Accounts Receivable -- -- -$2.4M -$2.2M -$16.6M
Change in Inventories -- -- -$4.3M -$3.4M $611K
Cash From Operations -$33.7M -$40.9M -$67.7M -$44M -$34.7M
 
Capital Expenditures -- -- $23M $64K $143K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$91.7M $3.5M -$197.3M $45.5M $84.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $125M -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$471K -- -$2.2M -- --
Cash From Financing -$437K $63K $285M $867K $394K
 
Beginning Cash (CF) $171.5M $90.7M $62.7M $106M $84.9M
Foreign Exchange Rate Adjustment -- -- -- -$75K $98K
Additions / Reductions -$125.8M -$37.4M $20M $2.4M $50.5M
Ending Cash (CF) $45.7M $53.3M $82.8M $108.4M $135.5M
 
Levered Free Cash Flow -$33.8M -$41M -$90.7M -$44M -$34.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$114.2M -$169.1M -$310.8M -$267.9M -$195.5M
Depreciation & Amoritzation $111K $353K $723K $1.5M $2.5M
Stock-Based Compensation $5.8M $20.8M $29.1M $39.3M $41.1M
Change in Accounts Receivable -- -- -$2.4M -$17M -$39.5M
Change in Inventories -- -- -$4.3M -$9.6M $644K
Cash From Operations -$97.3M -$155.5M -$238.4M -$261.9M -$167.7M
 
Capital Expenditures -- -- $23M $545K $149K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$141.9M -$175.3M -$105.9M $284.6M -$68.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $261.7M $338.4M $373.7M $3M $262.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $22.5M $7.6M $29.5M $25.7M $27M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$97.5M -$156.4M -$261.8M -$262.4M -$167.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$101.6M -$135M -$239.4M -$195.9M -$129.3M
Depreciation & Amoritzation $87K $318K $587K $1.1M $2.1M
Stock-Based Compensation $5.3M $18.2M $23.4M $30.1M $32.3M
Change in Accounts Receivable -- -- -$2.4M -$11M -$33.1M
Change in Inventories -- -- -$4.3M -$6.4M -$135K
Cash From Operations -$80.5M -$122.9M -$186.7M -$190.8M -$111.4M
 
Capital Expenditures -- -- $23M $422K $143K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$105.9M -$99.5M -$129.4M $242.4M -$6.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $125M -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$471K -- -$2.2M -- --
Cash From Financing $168.8M $209.1M $300.8M $2M $163.6M
 
Beginning Cash (CF) $425.8M $447.5M $231.8M $243.2M $364.9M
Foreign Exchange Rate Adjustment -- -- -- -$118K -$1000
Additions / Reductions -$17.6M -$13.3M -$15.2M $53.6M $46.1M
Ending Cash (CF) $408.1M $434.2M $216.6M $296.8M $411.1M
 
Levered Free Cash Flow -$80.6M -$123.7M -$209.8M -$191.2M -$111.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock